Business of the House Debate

Full Debate: Read Full Debate
Department: Leader of the House

Business of the House

Jeremy Lefroy Excerpts
Thursday 8th May 2014

(10 years ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Lansley Portrait Mr Lansley
- Hansard - - - Excerpts

The hon. Lady will understand that the provisions for sittings in Westminster Hall are determined by Standing Orders. It is not in my gift to change Standing Orders; it is a matter for the House, but as she rightly asks the question, I will look at what provisions in Standing Orders permit us to bring debates forward in Westminster Hall more speedily after the opening of a new Session.

Jeremy Lefroy Portrait Jeremy Lefroy (Stafford) (Con)
- Hansard - -

Yesterday at Prime Minister’s questions the subject was raised of the deeply worrying lack of a pipeline of new antibiotics, owing to market failure. May we have a debate on how the UK, perhaps through the Department of Health and the Department for International Development, can take the lead in a global initiative to support the development of new antibiotics, similar to that which has been so successful in producing new malaria drugs?

Lord Lansley Portrait Mr Lansley
- Hansard - - - Excerpts

My hon. Friend is right. The Prime Minister rightly stressed the importance of this, which he has discussed with the chief medical officer directly. The chief medical officer made an important report on the subject, in addition to her annual report. Last year we published the UK’s five-year anti-microbial resistance plan. That is world-leading, but it would be better if we were able to work with others. The World Health Organisation’s report gives us the basis on which to work with others at stimulating the necessary research to develop new antibiotics. If we can make sure that we use antibiotics more sensibly in the meantime, that will prolong far into the future the effective use of the existing supply of antibiotics, the stocks available and the kinds of antibiotics available at present.